BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
5.87
0.60 (11.39%)
At close: Jun 06, 2025, 1:35 PM

BioLineRx Statistics

Share Statistics

BioLineRx has 3.72M shares outstanding. The number of shares has increased by 74.04% in one year.

3.72M
74.04%
34.18%
0%
n/a
770
0.12%

Short Selling Information

The latest short interest is 181.45K, so 4.88% of the outstanding shares have been sold short.

181.45K
4.88%
4.89%
13.47

Valuation Ratios

The PE ratio is -74.15 and the forward PE ratio is -17.96. BioLineRx's PEG ratio is 0.84.

-74.15
-17.96
23.63
1
50.79
-15.56
0.84
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioLineRx.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.12.

1.76
1.56
1.12
3.84
-0.34
-2.25

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$1,033,571.43
$-329,321.43
28
0.74
2.95

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -81.41% in the last 52 weeks. The beta is 0.86, so BioLineRx's price volatility has been higher than the market average.

0.86
-81.41%
3.29
10.61
69.71
625,819

Income Statement

In the last 12 months, BioLineRx had revenue of 28.94M and earned -9.22M in profits. Earnings per share was -0.12.

28.94M
19.68M
-20.41M
-9.22M
3.92M
-147K
-0.12
Full Income Statement

Balance Sheet

The company has 10.44M in cash and 15.04M in debt, giving a net cash position of -4.6M.

10.44M
15.04M
-4.6M
-399.83M
38.91M
11.7M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.87M and capital expenditures -54K, giving a free cash flow of -43.93M.

-43.87M
-54K
-43.93M
-0.04
Full Cash Flow Statement

Margins

Gross margin is 67.99%, with operating and profit margins of -70.52% and -31.86%.

67.99%
-70.52%
-31.86%
-31.86%
13.54%
-70.52%
-151.79%

Dividends & Yields

BLRX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BLRX is $19, which is 266.8% higher than the current price. The consensus rating is "Buy".

$19
266.8%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 30, 2025. It was a backward split with a ratio of 1:40.

Jan 30, 2025
backward
1:40

Scores

-12.83
3